ValueSet-2.16.840.1.113883.3.1444.5.226

This value set contains 21 concepts

Code	System	Display
180223008	http://snomed.info/sct	Intravenous immunotherapy (procedure)
180244008	http://snomed.info/sct	Intramuscular immunotherapy (procedure)
180256009	http://snomed.info/sct	Subcutaneous immunotherapy (procedure)
589631000119102	http://snomed.info/sct	Intravenous radioimmunotherapy using monoclonal antibodies (procedure)
60827006	http://snomed.info/sct	Lymphokine activated killer cell therapy (procedure)
64644003	http://snomed.info/sct	Immunotherapy for cancer (procedure)
72255009	http://snomed.info/sct	Interleukin-2 therapy (procedure)
76334006	http://snomed.info/sct	Immunotherapy (procedure)
84501003	http://snomed.info/sct	Cytokine therapy (procedure)
870387009	http://snomed.info/sct	Immune checkpoint inhibitor therapy (procedure)
96365	http://www.ama-assn.org/go/cpt	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	http://www.ama-assn.org/go/cpt	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
96372	http://www.ama-assn.org/go/cpt	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
96374	http://www.ama-assn.org/go/cpt	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug
96401	http://www.ama-assn.org/go/cpt	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96409	http://www.ama-assn.org/go/cpt	Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96413	http://www.ama-assn.org/go/cpt	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	http://www.ama-assn.org/go/cpt	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
96416	http://www.ama-assn.org/go/cpt	Chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump
Q2041	http://www.nlm.nih.gov/research/umls/hcpcs	Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Q2042	http://www.nlm.nih.gov/research/umls/hcpcs	Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose